IVIM Health vs RxActivate: Pricing, reviews, and program differences
Comparing IVIM Health vs RxActivate quickly: IVIM Health offers clearly published starting prices, a clinician-guided GLP-1 ID protocol, and dual 4.9-star third-party ratings; RxActivate requires an eligibility questionnaire and hides pricing behind contact capture. Verdict: IVIM Health is more transparent on price and third-party satisfaction, while RxActivate emphasizes clinician matching and eligibility screening.
Explore IVIM Health pricing and GIFT75 offer
Key differences at a glance: pricing, reviews, gating, protocol, and compounded status
The most distinctive, supported differences between IVIM Health and RxActivate are pricing transparency, third-party review signals, intake gating and eligibility, proprietary protocol claims, and how compounded medications are presented. Each item below compares the two directly using only the supplied evidence.
Pricing transparency and cost
IVIM Health publishes starting and program prices: semaglutide listed at $75/mo and tirzepatide at $133/mo with a $74.99/mo program fee, plus an ongoing published rate noted in the FAQ (first month $99, $174/month ongoing) and a promotional free month with code GIFT75. RxActivate does not display any plan price or billing terms before users complete the eligibility questionnaire and provide contact information. If knowing upfront fees is important, IVIM Health is explicit while RxActivate requires contact to reveal pricing.
See IVIM Health membership details
Third-party reviews and satisfaction signals
IVIM Health is reported to have dual 4.9-star ratings on Google and Trustpilot, presented as an unusually strong satisfaction signal. RxActivate’s captured evidence does not include third-party star ratings; the available evidence focuses on the intake flow and member count claim. For external verification of patient satisfaction, IVIM Health provides named third-party ratings in the source.
Intake flow, eligibility, and gating
RxActivate centers its process on a two-minute eligibility questionnaire that requests goals, measurements, medication history, state and safety screening, and then requires name, email, and phone before showing plans or prices. IVIM Health offers a no-obligation free consultation and promotional code options that lower upfront barriers without a pre-price contact gate. RxActivate emphasizes clinician matching subject to eligibility screening, while IVIM presents a free consult and published fees.
Start RxActivate eligibility questionnaire
Proprietary program claims and clinical evidence
IVIM Health promotes a proprietary GLP-1 ID protocol and cites internal publications and retrospective observational studies claiming accelerated weight loss and specific relative outcomes including a 46% average more weight loss over 68 weeks compared to a published GLP-1 trial, with explicit qualifiers that this is not a head-to-head randomized trial and that the 40% protocol claim is IVIM’s own. RxActivate does not present provider-published outcome claims in the captured evidence; its materials focus on matching to clinician-reviewed plans. Where program outcome claims matter, IVIM supplies published internal studies and an explicit protocol claim with qualifiers.
Compounded medication and regulatory notes
Both providers present compounded medication contextually. IVIM Health repeatedly notes that some offerings are compounded and states that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. The RxActivate capture notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both sources preserve regulatory cautions; IVIM supplies extensive site language about compounded risks and supervision.
| Criterion | IVIM Health | RxActivate |
|---|---|---|
| Price visibility | Published starting prices ($75/mo semaglutide, $133/mo tirzepatide) and FAQ rates | Pricing gated until eligibility questionnaire and contact info |
| Third-party reviews | 4.9 stars on Google and Trustpilot reported | No third-party star ratings captured |
| Intake process | No-obligation free consultation included; promotional code GIFT75 | Two-minute eligibility questionnaire then contact gate |
| Program claims | Proprietary GLP-1 ID protocol; published internal observational studies cited with qualifiers | Clinician-matched plans emphasized; outcome claims not captured |
| Compounded meds | Compounded offerings noted; explicit regulatory caution about FDA review | Notes that compounded and branded products are not interchangeable; approval status must be confirmed |
How each provider suits different users
IVIM Health is best for people who prioritize published pricing, third-party verification, and a named clinician-guided protocol with published internal studies. RxActivate is best for people who want clinician matching and state and medical-safety screening upfront in the intake flow even if pricing is gated behind contact details.
Begin RxActivate intake to check eligibility
Compare IVIM Health membership and free consult
Bottom line on IVIM Health vs RxActivate
In short, IVIM Health vs RxActivate comes down to transparency versus gated clinician matching. IVIM Health publishes starting prices, offers a free consultation and promotes dual 4.9-star reviews and a proprietary GLP-1 ID protocol with cited internal studies. RxActivate requires an eligibility questionnaire and personal contact information before revealing price and emphasizes clinician-matched plans and state safety screening.
Choose IVIM Health if you want published starting prices, an included no-obligation consultation, and strong third-party review signals. Choose RxActivate if you prefer clinician matching through an eligibility flow and are willing to complete the intake to learn plan details and pricing. These choices are based only on the supplied source evidence about IVIM Health and RxActivate.